This event is associated with a clinical trial, sponsored by biosense webster, inc.Initially, the principal investigator assessed hypotension and dyspnea as not reportable as they were patient event non serious.In addition, the principal investigator assessed pneumonia and acute respiratory distress syndrome that resulted in the patient¿s non-cardiovascular death as not reportable as they were unrelated to the investigational device and unrelated to the procedure.Additional information was received on (b)(6) 2019 stating the principal investigator assessed pneumonia as not investigational device related and probably index procedure related.Also, acute respiratory distress syndrome that resulted in the patient¿s non-cardiovascular death as not investigational device related and possibly index procedure related.Therefore, for the adverse events of pneumonia, acute respiratory distress syndrome and death were assessed as mdr reportable.The awareness date for these reportable adverse events is (b)(4) 2019.It was reported that a (b)(6) female patient underwent an ablation procedure for paroxysmal atrial fibrillation with a thermocool® smart touch¿ bi-directional navigation catheter and suffered hypotension (requiring a new medication), dyspnea (requiring physiotherapy), pneumonia (requiring medication and mechanical ventilation) acute respiratory distress syndrome (requiring medication and mechanical ventilation) and death.On post-procedure day 3, the patient developed hypotension.An unspecified medication was administered.Issue is ongoing and improved.Principal investigator assessed this event as moderate in severity, not serious, not investigational device-related, and possibly index procedure-related.On post-procedure day 3, the patient developed dyspnea.Intervention was physiotherapy.Issue is ongoing and unchanged.Principal investigator assessed this event as moderate in severity, not serious, not investigational device-related, and possibly index procedure-related.On post-procedure day 8, the patient developed pneumonia.An unspecified medication was administered.Mechanical ventilation was also required.The patient required in-patient hospitalization.Issue is ongoing and worsened.Principal investigator assessed this event as severe, serious, not investigational device related and probably index procedure related.On post-procedure day 27, the patient developed acute respiratory distress syndrome.An unspecified medication was administered.Mechanical ventilation was also required.Extended hospitalization was required as a result of the adverse event.Patient¿s condition worsened, and the patient expired.Principal investigator assessed this event as severe, serious, not investigational device related and possibly index procedure related.
|